Literature DB >> 458051

Acoustical and perceptual characteristics of speech produced with an electronic artificial larynx.

M S Weiss, G H Yeni-Komshian, J M Heinz.   

Abstract

Five normal-speaking adult males were taught to produce speech using an electrolarynx. Speech phoneme intelligibility was measured in a closed-set word discrimination test and through phonetic transcriptions of the spoken materials. Mean percentages of correct identification for the five talkers were 90% and 57% for the word-identification test and phonetic transcription, respectively. An analysis of perceptual confusions revealed that errors were most frequently associated with the voicing feature and that few manner or place of articulation errors occurred. Over the range of variables observed, the intensity of both the speech and the noise radiating directly from the electrolarynx, the spectrum of the radiated noise and speaking rate were not found to be determinants of intelligibility.

Entities:  

Mesh:

Year:  1979        PMID: 458051     DOI: 10.1121/1.382697

Source DB:  PubMed          Journal:  J Acoust Soc Am        ISSN: 0001-4966            Impact factor:   1.840


  4 in total

1.  Enhancement of electrolarynx speech using adaptive noise cancelling based on independent component analysis.

Authors:  H J Niu; M X Wan; S P Wang; H J Liu
Journal:  Med Biol Eng Comput       Date:  2003-11       Impact factor: 2.602

2.  Development and perceptual evaluation of amplitude-based F0 control in electrolarynx speech.

Authors:  Yoko Saikachi; Kenneth N Stevens; Robert E Hillman
Journal:  J Speech Lang Hear Res       Date:  2009-06-29       Impact factor: 2.297

3.  3D simulation of an audible ultrasonic electrolarynx using difference waves.

Authors:  Patrick Mills; Jason Zara
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

4.  A pneumatic Bionic Voice prosthesis-Pre-clinical trials of controlling the voice onset and offset.

Authors:  Farzaneh Ahmadi; Farzad Noorian; Daniel Novakovic; André van Schaik
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.